LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Suletud

SektorTervishoid

17.02 5.85

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

16.08

Max

17.2

Põhinäitajad
By Trading Economics
Sissetulek	-2.4M -19M
Aktsiakasum	-0.28
Kasumimarginaal	-2,018.63
Töötajad	75
EBITDA	-857K -19M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+29.03% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	29. okt 2025

Turustatistika
By TradingEconomics
Turukapital	54M 1.1B
Eelmine avamishind	11.17
Eelmine sulgemishind	17.02

Uudiste sentiment

By Acuity

50%

169 / 372 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. aug 2025, 23:09 UTC

Omandamised, ülevõtmised, äriostud

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22. aug 2025, 22:02 UTC

Omandamised, ülevõtmised, äriostud

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22. aug 2025, 22:02 UTC

Omandamised, ülevõtmised, äriostud

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22. aug 2025, 22:02 UTC

Omandamised, ülevõtmised, äriostud

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22. aug 2025, 22:02 UTC

Omandamised, ülevõtmised, äriostud

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22. aug 2025, 22:02 UTC

Omandamised, ülevõtmised, äriostud

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22. aug 2025, 21:23 UTC

Market Talk

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22. aug 2025, 21:18 UTC

Market Talk

US Economic Growth Seen Slowing This Year -- Market Talk

22. aug 2025, 21:18 UTC

Omandamised, ülevõtmised, äriostud

U.S. Takes 10% Stake in Intel -- Barrons.com

22. aug 2025, 21:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. aug 2025, 21:03 UTC

Market Talk

Mexican Stocks Close At Record High -- Market Talk

22. aug 2025, 20:58 UTC

Market Talk

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22. aug 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22. aug 2025, 20:56 UTC

Tulu

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22. aug 2025, 20:55 UTC

Tulu

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22. aug 2025, 20:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

22. aug 2025, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

22. aug 2025, 20:41 UTC

Omandamised, ülevõtmised, äriostud

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22. aug 2025, 20:24 UTC

Omandamised, ülevõtmised, äriostud

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22. aug 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22. aug 2025, 19:19 UTC

Market Talk

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22. aug 2025, 19:10 UTC

Market Talk

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22. aug 2025, 19:06 UTC

Market Talk

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22. aug 2025, 19:03 UTC

Market Talk

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22. aug 2025, 18:52 UTC

Omandamised, ülevõtmised, äriostud

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

29.03% tõus

12 kuu keskmine prognoos

Keskmine 22 USD 29.03%

Kõrge 22 USD

Madal 22 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

169 / 372 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.